Learn more at LeadIQ.com

Insights

Market Expansion Opportunities Nabriva Therapeutics plc has recently engaged in asset sales and collaborations, signaling market expansion. Explore partnerships with acquiring companies or distributors to leverage this growth.

New Product Launches With the launch of XENLETA and CONTEPO, Nabriva Therapeutics offers innovative anti-infective agents. Identify healthcare facilities experiencing high demand for novel antibiotics to introduce these products effectively.

Strategic Partnerships Partnerships with industry leaders like Merck and Er-Kim showcase Nabriva's collaborative approach. Capitalize on these relationships by exploring joint sales initiatives or co-promotions.

Technology Integration Opportunities Considering Nabriva's tech stack includes Adobe Tag Manager and Google Tag Manager, highlight technological compatibility to potential clients seeking advanced solutions. Offer seamless integrations for a competitive edge.

Targeted Marketing Campaigns Utilize Nabriva's focus on developing antibiotics for serious infections to tailor marketing campaigns. Highlight the efficacy and unique selling points of XENLETA and CONTEPO for targeted outreach to healthcare providers.

Similar companies to Nabriva Therapeutics plc

Nabriva Therapeutics plc Tech Stack

Nabriva Therapeutics plc uses 8 technology products and services including Backbone.js, React, jQuery, and more. Explore Nabriva Therapeutics plc's tech stack below.

Backbone.js
Javascript Frameworks
React
Javascript Frameworks
jQuery
Javascript Libraries
Open Graph
Miscellaneous
Akamai Web Application Protector
Security
Adobe Tag Manager
Tag Management
Google Tag Manager
Tag Management
Acquia Cloud Site Factory
Web Hosting

Media & News

Nabriva Therapeutics plc's Email Address Formats

Nabriva Therapeutics plc uses at least 1 format(s):

Nabriva Therapeutics plc Email Formats	Example	Percentage
First.Last@nabriva.com	John.Doe@nabriva.com	43%
Last@nabriva.com	Doe@nabriva.com	7%
First.Last@nabriva.com	John.Doe@nabriva.com	43%
Last@nabriva.com	Doe@nabriva.com	7%

Frequently Asked Questions

Where is Nabriva Therapeutics plc's headquarters located?

Nabriva Therapeutics plc's main headquarters is located at 25-28 North Wall Quay Dublin, - - IE. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Nabriva Therapeutics plc's phone number?

You can contact Nabriva Therapeutics plc's main corporate office by phone at

+43-4301-74****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nabriva Therapeutics plc's stock symbol?

Nabriva Therapeutics plc is a publicly traded company; the company's stock symbol is NBRVF.

What is Nabriva Therapeutics plc's official website and social media links?

Nabriva Therapeutics plc's official website is nabriva.com and has social profiles on LinkedIn.

How much revenue does Nabriva Therapeutics plc generate?

As of July 2024, Nabriva Therapeutics plc's annual revenue reached $15M.

What is Nabriva Therapeutics plc's SIC code NAICS code?

Nabriva Therapeutics plc's SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nabriva Therapeutics plc have currently?

As of July 2024, Nabriva Therapeutics plc has approximately 51 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: C. G.Vice President - Commercial Excellence: T. M.Executive Assistant To Cfo, Cco And Cio: C. R.. Explore Nabriva Therapeutics plc's employee directory with LeadIQ.

What industry does Nabriva Therapeutics plc belong to?

Nabriva Therapeutics plc operates in the Biotechnology Research industry.

What technology does Nabriva Therapeutics plc use?

Nabriva Therapeutics plc's tech stack includes Backbone.jsReactjQueryOpen GraphAkamai Web Application ProtectorAdobe Tag ManagerGoogle Tag ManagerAcquia Cloud Site Factory.

What is Nabriva Therapeutics plc's email format?

Nabriva Therapeutics plc's email format typically follows the pattern of . Find more Nabriva Therapeutics plc email formats with LeadIQ.

How much funding has Nabriva Therapeutics plc raised to date?

As of July 2024, Nabriva Therapeutics plc has raised $92M in funding. The last funding round occurred on Jan 01, 2015 for $92M.

When was Nabriva Therapeutics plc founded?

Nabriva Therapeutics plc was founded in 2006.

Nabriva Therapeutics plc

Nabriva Therapeutics plc

Biotechnology Research-, Ireland51-200 Employees

Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of novel antibiotics to treat serious infections. Nabriva Therapeutics has two products: Xenleta (lefamulin), recently approved by the FDA for both Oral and IV use and CONTEPO (fosfomycin) for injection, we submitted an NDA for CONTEPO, a potential first-in-class epoxide antibiotic in the United States for complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP). Our corporate headquarters are in Dublin, Ireland with offices and labs located in Vienna, Austria and King of Prussia, PA.

Nabriva is a commercial-stage biopharmaceutical company with locations in the
United States (King of Prussia, PA, San Diego, CA), Austria (Vienna), and Ireland (Dublin), home of our corporate headquarters.

Company Overview

Headquarters: 25-28 North Wall Quay Dublin, - - IE
Phone number: ✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+43-4301-74****
Website: nabriva.com
SIC Code: 2836 - Biological Products, Except Diagnostic Substances
Stock Symbol: NBRVF
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2006
Employees: 51-200

Media & News

Funding & Financials

$92M
Nabriva Therapeutics plc has raised a total of $92M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2015 in the amount of $92M.
$10M$50M
Nabriva Therapeutics plc's revenue is in the range of $10M$50M

Funding & Financials

$92M
Nabriva Therapeutics plc has raised a total of $92M of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2015 in the amount of $92M.
$10M$50M
Nabriva Therapeutics plc's revenue is in the range of $10M$50M

Company Leadership

C. G.
Chief Medical Officer
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. M.
Vice President - Commercial Excellence
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. R.
Executive Assistant To Cfo, Cco And Cio
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. M.
National Account Director - Trade/Gpo/Health Systems
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. C.
Sr. Vice President Of Quality At Nabriva Therapeutics
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

L. G.
Vice President, Clinical Research And Development
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. P.
Vice President, Microbiology
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. M.
Vice President - Commercial Excellence
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
W. S.
Vice President, Commercial Strategy
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. N.
Senior Director, Field Medical Affairs
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nabriva Therapeutics plc and Millions of Other Companies
Sign up for full access to Nabriva Therapeutics plc information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.